Meta-analyses of the effect of false-positive mammograms on generic and specific psychosocial outcomes

Psycho-Oncology

Volumn 19, Issue 10, 2010, Pages 1026-1034

  Salz, Talya ^a   Richman, Alice R ^b   Brewer, Noel T ^b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

breast neoplasm; cancer; false positive; mammography; oncology

Indexed keywords

ADULT; ANXIETY; ATTITUDE; BREAST CANCER; BREAST SELF EXAMINATION; CLINICAL EFFECTIVENESS; DEPRESSION; DISTRESS SYNDROME; FALSE POSITIVE RESULT; FEAR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDLINE; OUTCOME ASSESSMENT; PSYCHOLOGICAL WELL BEING; REVIEW; SOCIAL BELIEF; SOMATIZATION; WELLBEING;

ANXIETY; BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HEALTH BEHAVIOR; HUMANS; MAMMOGRAPHY; MASS SCREENING; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 78149405242     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1676     Document Type: Review

References (52)

1. Berry DA, Cronin KA, Pelvritis SK, et al,. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353 (17): 1784-1792.
2. Elmore JG, Barton MB, Moceri VM, et al,. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338 (16): 1089-1096.
3. Brewer NT, Salz T, Lillie SE,. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007; 146 (7): 502-510.
4. Gram IT, Lund E, Slenker SE,. Quality of life following a false positive mammogram. Br J Cancer 1990; 62 (6): 1018-1022.
5. Lampic C, Thurfjell E, Sjoden PO,. The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer. Eur J Cancer 2003; 39 (12): 1730-1737.
6. Brett J, Austoker J,. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med 2001; 23 (4): 292-300.
7. Beck A, Ward C, Mendelson M,. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
8. Zigmond A, Snaith R,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
9. Patrick DL, Deyo RA,. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27 (3 Suppl): S217-S232.
10. Ren XS, Kazis L, Lee A, et al,. Comparing generic and disease-specific measures of physical and role functioning: results from the Veterans Health Study. Med Care 1998; 36 (2): 155-166.
11. Ren XS, Kazis LE, Lee A, et al,. The role of generic and disease-specific measures of physical and role functioning in assessing patient outcomes: a longitudinal study. J Ambul Care Manage 2005; 28 (2): 157-166.
12. Ajzen I, Fishbein M,. Attitude-behavior relations: a theoretical analysis and review of empirical research. Psychol Bull 1977; 84 (5): 888-918.
13. Ajzen I, Timko C,. Correspondence between health attitudes and behavior. Basic Appl Soc Psychol 1986; 7 (4): 259-276.
14. Fazekas KI, Brewer NT, Smith JS,. HPV vaccine acceptability in a rural Southern area. J Womens Health (Larchmt) 2008; 17 (4): 539-548.
15. Tyndel S, Austoker J, Henderson BJ, et al,. What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol 2007; 25 (25): 3823-3830.
16. Aro AR, Pilvikki Absetz S, van Elderen TM, et al,. False-positive findings in mammography screening induces short-term distress-breast cancer-specific concern prevails longer. Eur J Cancer 2000; 36 (9): 1089-1097.
17. Cohen J,. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Lawrence Erlbaum Associates: Hillsdale, NJ, 1988.
18. Higgins J, Thompson S, Deeks J, et al,. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560.
19. Kosters JP, Gotzsche PC,. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2003;(2): CD003373.
20. Brodersen J, Thorsen H, Cockburn J,. The adequacy of measurement of short and long-term consequences of false-positive screening mammography. J Med Screen 2004; 11 (1): 39-44.
21. Goldberg D,. Manual of the General Health Questionnaire. NFER-Nelson Publishing: Windsor, United Kingdom, 1978.
22. Vickers AJ,. How to measure quality of life in integrative oncology research. J Soc Integr Oncol 2006; 4 (2): 100-103.
23. Wiebe S, Guyatt G, Weaver B, et al,. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003; 56 (1): 52-60.
24. Barton MB, Morley DS, Moore S, et al,. Decreasing women's anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst 2004; 96 (7): 529-538.
25. Blanton H, Jaccard J,. Arbitrary metrics in psychology. Am Psychol 2006; 61 (1): 27-41.
26. Cockburn J, De Luise T, Hurley S, et al,. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med 1992; 34 (10): 1129-1134.
27. Brett J, Austoker J, Ong G,. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med 1998; 20 (4): 396-403.
28. Ong G, Austoker J, Brett J,. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen 1997; 4 (3): 158-168.
29. Cockburn J, Staples M, Hurley SF, et al,. Psychological consequences of screening mammography. J Med Screen 1994; 1 (1): 7-12.
30. Meystre-Agustoni G, Paccaud F, Jeannin A, et al,. Anxiety in a cohort of Swiss women participating in a mammographic screening programme. J Med Screen 2001; 8 (4): 213-219.
31. Olsson P, Armelius K, Nordahl G, et al,. Women with false positive screening mammograms: how do they cope? J Med Screen 1999; 6 (2): 89-93.
32. Brodersen J, Thorsen H, Kreiner S,. Validation of a condition-specific measure for women having an abnormal screening mammography. Value Health 2007; 10 (4): 294-304.
33. Schwartz LM, Woloshin S, Fowler Jr FJ, et al,. Enthusiasm for cancer screening in the United States. JAMA 2004; 291 (1): 71-78.
34. Horowitz M, Wilner N, Alvarez W,. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41 (3): 209-218.
35. Ellman R, Angeli N, Christians A, et al,. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 1989; 60 (5): 781-784.
36. Lerman C, Trock B, Rimer BK, et al,. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991; 114 (8): 657-661.
37. Lerman C, Trock B, Rimer BK, et al,. Psychological side effects of breast cancer screening. Health Psychol 1991; 10 (4): 259-267.
38. Sandin B, Chorot P, Valiente RM, et al,. Adverse psychological effects in women attending a second-stage breast cancer screening. J Psychosom Res 2002; 52 (5): 303-309.
39. Derogatis LR,. SCL-90-R administration, scoring, and procedures manual II. Clinical Psychometric Research. Towson: MD, 1983.
40. Kellner R,. Abridged Manual of the Illness Attitude Scales. University of New Mexico: Albuquerque, NM, 1987.
41. Scaf-Klomp W, Sanderman R, van de Wiel HB, et al,. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997; 51 (6): 705-710.
42. Rickels K, Garcia CR, Lipman RS, et al,. The Hopkins Symptom Checklist. Assessing emotional distress in obstetric-gynecologic practice. Prim Care 1976; 3 (4): 751-764.
43. Bull AR, Campbell MJ,. Assessment of the psychological impact of a breast screening programme. Br J Radiol 1991; 64 (762): 510-515.
44. Jatoi I, Zhu K, Shah M, et al,. Psychological distress in U.S. women who have experienced false-positive mammograms. Breast Cancer Res Treat 2006; 100 (2): 191-200.
45. Kessler RC, Barker PR, Colpe LJ, et al,. Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003; 60 (2): 184-189.
46. Lampic C, Thurfjell E, Bergh J, et al,. Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 2001; 37 (4): 463-469.
47. Lipkus IM, Halabi S, Strigo TS, et al,. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psychooncology 2000; 9 (5): 402-410.
48. Andresen EM, Malmgren JA, Carter WB, et al,. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994; 10 (2): 77-84.
49. Spielberger C, Gorsuch R, Luchene R,. Manual for the State Trait Anxiety Inventory. Consulting Psychologists Pr: Palo Alto, CA, 1970.
50. Watson M, Duvivier V, Wade Walsh M, et al,. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998; 35 (9): 731-738.
51. Pisano ED, Earp JA, Gallant TL,. Screening mammography behavior after a false positive mammogram. Cancer Detect Prev 1998; 22 (2): 161-167.
52. Rakowski W, Anderson MR, Stoddard AM, et al,. Confirmatory analysis of opinions regarding the pros and cons of mammography. Health Psychol 1997; 16 (5): 433-441.